API Category: Anti-cancer

Capecitabine is part of our Anti-cancer portfolio.

CAS Number: 154361-50-9

Gemcitabine is part of our Anti-cancer portfolio.

CAS Number: 95058-81-4

Olaparib is part of our Anti-cancer portfolio.

CAS Number: 763113-22-0

Doxorubicin is part of our Anti-cancer portfolio.

CAS Number: 23214-92-8

Mitomycin C is part of our Anti-cancer portfolio.

CAS Number: 50-07-7

Bendamustine HCl is part of our Anti-cancer portfolio.

CAS Number: 3543-75-7

Imatinib Mesylate is part of our Anti-cancer portfolio.

CAS Number: 220127-57-1

Dasatinib is part of our Anti-cancer portfolio.

CAS Number: 302962-49-8

Lapatinib is part of our Anti-cancer portfolio.

CAS Number: 231277-92-2

Letrozole is part of our Anti-cancer portfolio.

CAS Number: 112809-51-5